Alloplex Biotherapeutics is a privately held Boston based cellular therapeutics company. Their lead oncology therapeutic is a PBMC-derived multicellular adoptive immunotherapy which we call SUPLEXA cells. Alloplex comes to us referred by Andy Luber, Keiretsu member and CEO of Virion Therapeutics.